Driehaus Capital Management
Driehaus Capital Management reported 354 stocks worth $17.3B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TSM (2.7%), DFTX (1.9%) and PRAX (1.9%). Compared with Q1 2026, the fund opened new positions in CRDO, CDNS and ALAB, added to DFTX, PRAX and SIMO, trimmed TSM, XENE and PL and sold out of EYE, YUMC and BBIO.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  TSM Taiwan Semiconductor Mfg Ltd | $470M | 2.7% | 985K | −280K (−22%) | 8 of 8 | |
| 2 |  DFTX Definium Therapeutics Inc | $322M | 1.9% | 6.8M | +933K (+16%) | 3 of 8 | |
| 3 |  PRAX Praxis Precision Medicines I | $321M | 1.9% | 959K | +9,823 (+1%) | 8 of 8 | |
| 4 |  XENE Xenon Pharmaceuticals Inc | $267M | 1.6% | 4.4M | −73K (−2%) | 8 of 8 | |
| 5 |  SIMO Silicon Motion Technology Co | $262M | 1.5% | 786K | +276K (+54%) | 5 of 8 | |
| 6 |  SYRE Spyre Therapeutics Inc | $249M | 1.4% | 2.8M | +8,381 (+0%) | 8 of 8 | |
| 7 | CRINETICS PHARMACEUTICALS IN | $242M | 1.4% | 6.5M | +68K (+1%) | 8 of 8 | |
| 8 | APOGEE THERAPEUTICS INC | $231M | 1.3% | 1.7M | −181K (−9%) | 8 of 8 | |
| 9 |  GH Guardant Health Inc | $230M | 1.3% | 1.5M | +9,703 (+1%) | 6 of 8 | |
| 10 |  PL Planet Labs Pbc | $223M | 1.3% | 6.7M | −1.2M (−15%) | 5 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 EYE National Vision Hldgs Inc | $89.9M | 3.5M |
 YUMC Yum China Hldgs Inc | $89.3M | 1.8M |
 BBIO Bridgebio Pharma Inc | $85.2M | 1.1M |
 KRMN Karman Hldgs Inc | $78.2M | 977K |
 FTI Technipfmc PLC | $71.9M | 1M |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Driehaus Capital Management 13F FAQ
What does Driehaus Capital Management own?
Driehaus Capital Management reported 354 stocks worth $17.3B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TSM (2.7%), DFTX (1.9%) and PRAX (1.9%). The table above lists every position in the filing (the top 10 without an account).
What did Driehaus Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 84 new positions, 140 added to, 107 trimmed and 85 sold out. New positions include CRDO, CDNS and ALAB. It sold all of EYE, YUMC and BBIO.
When will Driehaus Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Driehaus Capital Management's portfolio worth?
The Q2 2026 filing reports $17.3B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.